In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

VIDEOS

GRACE sat down with Dr. Marco Ruiz to discuss information regarding the role of surveillance imaging in indolent lymphomas and chronic lymphocytic...

GRACE sat down with Dr. Marco Ruiz to discuss information regarding all diffuse large B-cell lymphoma (DLBCL) and are they made equally ("¿Todos los...

Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses Is There An Optimal Chemo Regimen For Squamous Non-Small Cell Lung Cancer (NSCLC).

GRACE sat down with Dr. Marco Ruiz to discuss "What are the risks and benefits of Ibrutinib and Idelalisib?" for our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments.

Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses if there is a role for PD-L1 testing after first line treatment.

ARTICLES

From the GRACE Archives -- Originally Published August 28, 2011 | By Dr. West A little over a decade ago, two important cancer biologists published a...
From the GRACE Archives -- Originally Published August 28, 2011 | By Dr. West A little over a decade ago, two important cancer biologists published a...

GRACE is excited to announce that it has partnered with MORE Health. MORE Health, a global healthcare company, helped to sponsor this year's GRACE...

From the GRACE Archives | Originally Published March 17, 2012 | By Dr West While the idea of staging a cancer is to get the best sense possible of the...
From the GRACE Archives | Originally Published March 17, 2012 | By Dr West While the idea of staging a cancer is to get the best sense possible of the...

COMMUNITY FORUM

I'm posting this for Carol as she couldn't figure out how to do it. "After eight clear years after a thoracotomy in 2010 my latest scan shows multiple...
My wife got her first CT scan back from the Kadcyla treatment. Classified as stable overall!! The lung remains the same - seems to be just small...
I had BAC in 2000 at age 46. They removed my RUL and RML for a 10 cm tumor. This was followed by 7 weeks concurrent chemo and radiation because of a 0...
Well, the first CT scan with Kadcyla is still a month or more away, so ne news there. My wife is feeling great, so we are hoping the next CT will be...
My freind is diagonised with cancer and in early stage she realise that. She decided to go with Ayurveda treatment. Ayurveda treatment shows their...

Recent Comments

Hi Scub Oak, it's good to…
Comment By scruboak on Oct 26, 2022 7:55 pm
Invasive mucinous adenocarcinoma
Comment By JanineT GRACE … on Oct 30, 2022 9:41 pm
So good to hear from you Jim…
Comment By JanineT GRACE … on Oct 25, 2022 3:06 pm
New nodule
Comment By JanineT GRACE … on Oct 25, 2022 3:06 pm

First Line Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Great Option for Some, but Not for All

Article

General-Campaign-Logo-300x300Several weeks ago, at a very crowded plenary session for the European Society of Medical Oncology (ESMO) in Copenhagen, Denmark, results with first line immunotherapy compared to standard first line chemotherapy for patients with advanced non-small cell lung cancer (NSCLC) were presented that simultaneously ushered in a new era for testing for PD-L1, the leading predictive marker for sensitivity to immu

Subscribe to In Treatment